Role of the adaptor protein PDZK1 in controlling the HDL receptor SR-BI

被引:63
作者
Kocher, Olivier [1 ]
Krieger, Monty [2 ]
机构
[1] Harvard Univ, Sch Med, Dept Pathol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] MIT, Dept Biol, Cambridge, MA USA
基金
美国国家卫生研究院;
关键词
atherosclerosis; endothelium; high-density lipoprotein receptor; PDZ domains; HIGH-DENSITY-LIPOPROTEIN; HEPATIC SCAVENGER RECEPTOR; REVERSE CHOLESTEROL TRANSPORT; CORONARY-HEART-DISEASE; NITRIC-OXIDE SYNTHASE; LDL RECEPTOR; DEFICIENT MICE; RECESSIVE HYPERCHOLESTEROLEMIA; SURFACE LOCALIZATION; TARGETED DISRUPTION;
D O I
10.1097/MOL.0b013e32832aee82
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purpose of review Regulation of lipoprotein receptor activity influences lipoprotein metabolism, related physiology and pathophysiology. Adaptor proteins that bind to the LDL or HDL receptors apparently link these receptors to cellular components essential for their normal functioning. Here, we focus on the influence of PDZK1 on the HDL receptor scavenger receptor class B type I (SR-BI), with emphasis on the roles played by its individual PDZ domains, the impact in regulating HDL metabolism and the relevance for cardiovascular disease. Recent findings PDZK1 plays an essential role in maintaining hepatic SR-BI levels and controlling HDL metabolism, protects against the development of atherosclerosis in a murine model and also mediates SR-BI-dependent regulation of endothelial cell biology by HDL, suggesting that PDZK1 plays multiple roles in normal physiology and may influence associated disorder. All four PDZ domains of PDZK1 appear necessary to promote normal hepatic expression, function and intracellular localization of SR-BI. Summary SR-BI mediates several features of HDL metabolism and function, some of which depend on SR-BI's interaction with PDZK1. Exploration of the structure and function of PDZK1 and the mechanisms by which it controls SR-BI will provide additional insights into HDL metabolism and may provide the basis for new therapeutic modalities for cardiovascular disease.
引用
收藏
页码:236 / 241
页数:6
相关论文
共 65 条
[1]   Identification of scavenger receptor SR-BI as a high density lipoprotein receptor [J].
Acton, S ;
Rigotti, A ;
Landschulz, KT ;
Xu, SZ ;
Hobbs, HH ;
Krieger, M .
SCIENCE, 1996, 271 (5248) :518-520
[2]   Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene [J].
Arai, T ;
Wang, N ;
Bezouevski, M ;
Welch, C ;
Tall, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (04) :2366-2371
[3]   Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor-BI mediate HDL-initiated signaling [J].
Assanasen, C ;
Mineo, C ;
Seetharam, D ;
Yuhanna, IS ;
Marcel, YL ;
Connelly, MA ;
Williams, DL ;
de la Llera-Moya, M ;
Shaul, PW ;
Silver, DL .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (04) :969-977
[4]   Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse [J].
Braun, A ;
Zhang, SW ;
Miettinen, HE ;
Ebrahim, S ;
Holm, TM ;
Vasile, E ;
Post, MJ ;
Yoerger, DM ;
Picard, MH ;
Krieger, JL ;
Andrews, NC ;
Simons, M ;
Krieger, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (12) :7283-7288
[5]   Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice [J].
Braun, A ;
Trigatti, BL ;
Post, MJ ;
Sato, K ;
Simons, M ;
Edelberg, JM ;
Rosenberg, RD ;
Schrenzel, M ;
Krieger, M .
CIRCULATION RESEARCH, 2002, 90 (03) :270-276
[6]  
Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489
[7]   Molecular mechanisms of autosomal recessive hypercholesterolemia [J].
Cohen, JC ;
Kimmel, M ;
Polanski, A ;
Hobbs, HH .
CURRENT OPINION IN LIPIDOLOGY, 2003, 14 (02) :121-127
[8]   Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells [J].
Covey, SD ;
Krieger, M ;
Wang, W ;
Penman, M ;
Trigatti, BL .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (09) :1589-1594
[9]   Crystal structures of a complexed and peptide-free membrane protein-binding domain: Molecular basis of peptide recognition by PDZ [J].
Doyle, DA ;
Lee, A ;
Lewis, J ;
Kim, E ;
Sheng, M ;
MacKinnon, R .
CELL, 1996, 85 (07) :1067-1076
[10]   Overexpression of the PDZ1 domain of PDZK1 blocks the activity of hepatic scavenger receptor, class B, type I by altering its abundance and cellular localization [J].
Fenske, Sara A. ;
Yesilaltay, Ayce ;
Pal, Rinku ;
Daniels, Kathleen ;
Rigotti, Attilio ;
Krieger, Monty ;
Kocher, Olivier .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (32) :22097-22104